Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

First report of hypoglycemia secondary to dandelion (Taraxacum officinale) ingestion.

Goksu E, Eken C, Karadeniz O, Kucukyilmaz O.

Am J Emerg Med. 2010 Jan;28(1):111.e1-2. doi: 10.1016/j.ajem.2009.02.021. No abstract available.

PMID:
20006217
[PubMed - indexed for MEDLINE]
3.
4.

The insulin-plus-sugar method for controlling recently diagnosed type 2 diabetes without hypoglycemia.

Shohet I, Hashim S.

Diabetes Care. 2000 Mar;23(3):416-7. No abstract available.

PMID:
10868875
[PubMed - indexed for MEDLINE]
Free Article
5.

Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE study.

Sreenan S, Virkamäki A, Zhang K, Hansen JB; PREDICTIVE study group.

Int J Clin Pract. 2008 Dec;62(12):1971-80. doi: 10.1111/j.1742-1241.2008.01939.x. Erratum in: Int J Clin Pract. 2009 Jan;63(1):176-7:178-80.

PMID:
19166444
[PubMed - indexed for MEDLINE]
6.

Insulin lispro for the treatment of type 2 diabetes.

Fisher M.

Hosp Med. 1999 Nov;60(11):802-6. Review.

PMID:
10707190
[PubMed - indexed for MEDLINE]
7.

Are long-acting insulin analogues better than isophane insulin?

Schooff MD, Gupta L.

Am Fam Physician. 2008 Feb 15;77(4):447-9. Review. No abstract available.

PMID:
18326162
[PubMed - indexed for MEDLINE]
Free Article
8.

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.

Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A.

Diabetes Care. 2005 Apr;28(4):950-5.

PMID:
15793205
[PubMed - indexed for MEDLINE]
9.

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB.

Diabetes Care. 2001 Apr;24(4):631-6.

PMID:
11315821
[PubMed - indexed for MEDLINE]
10.

Improved glycemic control with decreased hypoglycemia prevents long-term complications in type 2 diabetes patients: long-term simulation analysis using the "diabetes mellitus model".

Maxion-Bergemann S, Huppertz E, Jacobs LD, Müller E, Walleser S.

Int J Clin Pharmacol Ther. 2005 Jun;43(6):271-81.

PMID:
15968884
[PubMed - indexed for MEDLINE]
11.

Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials.

Garber AJ, Clauson P, Pedersen CB, Kølendorf K.

J Am Geriatr Soc. 2007 Nov;55(11):1735-40.

PMID:
17979896
[PubMed - indexed for MEDLINE]
12.

Reconsideration of severe hypoglycemic events in the treat-to-target trial.

Dailey G, Strange P, Riddle M.

Diabetes Technol Ther. 2009 Aug;11(8):477-9. doi: 10.1089/dia.2009.0022.

PMID:
19698059
[PubMed - indexed for MEDLINE]
13.

[Insulin detemir compared with NPH insulin. No significant differences identified in the studies].

Liedholm H, Linné AB.

Lakartidningen. 2006 May 3-9;103(18):1417, 1419-22, 1424-6. Review. Swedish. No abstract available.

PMID:
16729454
[PubMed - indexed for MEDLINE]
14.

Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.

Duckworth W, Davis SN.

J Diabetes Complications. 2007 May-Jun;21(3):196-204. Review.

PMID:
17493554
[PubMed - indexed for MEDLINE]
15.

Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes.

de Luis DA, Aller R, Cuellar L, Terroba C, Ovalle H, Izaola O, Romero E.

Diabetes Care. 2001 Oct;24(10):1844-5. No abstract available.

PMID:
11574456
[PubMed - indexed for MEDLINE]
16.

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.

Rosenstock J, Fonseca V, McGill JB, Riddle M, Hallé JP, Hramiak I, Johnston P, Davis M.

Diabetologia. 2009 Sep;52(9):1778-88. doi: 10.1007/s00125-009-1415-7. Epub 2009 Jun 13.

PMID:
19526210
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study.

Taylor R, Davies R, Fox C, Sampson M, Weaver JU, Wood L.

Diabetes Care. 2000 Nov;23(11):1612-8.

PMID:
11092282
[PubMed - indexed for MEDLINE]
Free Article
18.

Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.

Dailey G, Strange P.

Am J Manag Care. 2008 Jan;14(1):25-30.

PMID:
18197742
[PubMed - indexed for MEDLINE]
Free Article
19.

Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients.

Pan CY, Sinnassamy P, Chung KD, Kim KW; LEAD Study Investigators Group.

Diabetes Res Clin Pract. 2007 Apr;76(1):111-8. Epub 2006 Oct 2.

PMID:
17011662
[PubMed - indexed for MEDLINE]
20.

The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes.

Standl E, Lang H, Roberts A.

Diabetes Technol Ther. 2004 Oct;6(5):579-88.

PMID:
15628811
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk